Pulmonary hypertension affects about 1% of the global population ... Treatment options can vary depending on the type of ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

The oxygen-sensing protein HIF-1alpha may contribute to worsening pulmonary arterial hypertension (PAH) and is a possible ...

PAH is a rare type of pulmonary hypertension, which is marked by high blood pressure in the vessels that ... people with or ...

Co. Ltd. has identified pyrazolecarbonyl piperazinone compounds acting as bone morphogenetic protein receptor type-1B (BMPR1B) inhibitors reported to be useful for the treatment of cancer and ...